BGB-A317-A445-101
Completed
Safety and Preliminary Effectiveness of BGB-A445 in Combination With Tislelizumab in Participants With Advanced Solid Tumors
BeOne Study ID
BGB-A317-A445-101
ClinicalTrials.gov ID
EudraCT or EUCT Number
2022-501177-39-00
China Drug Trials ID
CTR20220453
Study Overview
Sex: All
Age: 18 Years / N/A
Accepts Healthy Volunteers? No
No Study Documents
Study Overview
Sex: All
Age: 18 Years / N/A
Accepts Healthy Volunteers? No
No Study Documents